comparemela.com

Latest Breaking News On - Lifesciences india - Page 1 : comparemela.com

SMS Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023

SMS Lifesciences India Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 720.53 million.

Lifesciences indiaIndia limited

SMS Lifesciences India Ltd consolidated Q1 FY2023-24 loss widens to Rs 1 79 crore

SMS Lifesciences India Ltd consolidated Q1 FY2023-24 loss widens to Rs 1 79 crore
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Sms lifesciences india ltdLifesciences indiaIndia ltdIndia limited

DGCI cancels license of 18 pharma firms, months after cough syrup deaths

The decision by the DGCA was taken after it examined 76 enterprises across 20 states and union territories, with close to 203 firms being identified for review.

Madhya pradeshHimachal pradeshAnrose pharmaBalaji pharmatechMadhya pradesh nestor pharmaceuticalsGnosis pharmaceuticals privateAthens life sciencesShri ramesh industriesLaborate pharmaceuticals indiaMedica labTrugen pharmaceuticalsRhydburg pharmaceuticalsAlliance biotechPark pharmaceuticalsEg pharmaceuticalsLifesciences india

DGCI Cancels Licences of 18 Pharma Firms on Allegations of Spurious Drugs, Check List Here

Most of these companies are from Uttarakhand and Himachal Pradesh, with two from Madhya Pradesh and one each from Haryana and Maharashtra. aaa

Himachal pradeshMadhya pradeshNew delhiAnrose pharmaMansukh mandaviyaSykmap pharmacuticalsBalaji pharmatechLaborate pharmaceuticals india ltdMascot health seriesTrugen pharmaceuticalsLifesciences indiaVintochem pharmaceuticalsEg pharmaceuticalsAthens life sciencesRhydburg pharmaceuticalsPharmaceuticals research

SMS Lifesciences India Ltd Q3FY23 consolidated profit higher at Rs 3 98 crore

The Board of Directors of SMS Lifesciences India Limited have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23, 9MFY23 at its board meeting.

Lifesciences indiaSms lifesciences india ltdIndia limited

vimarsana © 2020. All Rights Reserved.